135 related articles for article (PubMed ID: 21684324)
1. Genetically engineered mouse models of diffuse gliomas.
Schmid RS; Vitucci M; Miller CR
Brain Res Bull; 2012 May; 88(1):72-9. PubMed ID: 21684324
[TBL] [Abstract][Full Text] [Related]
2. Review: low-grade gliomas as neurodevelopmental disorders: insights from mouse models of neurofibromatosis-1.
Thangarajh M; Gutmann DH
Neuropathol Appl Neurobiol; 2012 Jun; 38(3):241-53. PubMed ID: 22035280
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of new transgenic mouse models in glioma research.
Sonabend AM; Ulasov IV; Lesniak MS
Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
[TBL] [Abstract][Full Text] [Related]
4. Gliomagenesis: genetic alterations and mouse models.
Holland EC
Nat Rev Genet; 2001 Feb; 2(2):120-9. PubMed ID: 11253051
[TBL] [Abstract][Full Text] [Related]
5. Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profile.
Hirose Y; Sasaki H; Miwa T; Ohba S; Ikeda E; Abe M; Ikeda S; Kobayashi M; Kawase T; Hasegawa M; Yoshida K
Neurosurgery; 2011 Aug; 69(2):376-90. PubMed ID: 21358357
[TBL] [Abstract][Full Text] [Related]
6. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
[TBL] [Abstract][Full Text] [Related]
7. Applications of mouse glioma models in preclinical trials.
Hu X; Holland EC
Mutat Res; 2005 Aug; 576(1-2):54-65. PubMed ID: 16011838
[TBL] [Abstract][Full Text] [Related]
8. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
9. Rethinking pediatric gliomas as developmental brain abnormalities.
Crouse NR; Dahiya S; Gutmann DH
Curr Top Dev Biol; 2011; 94():283-308. PubMed ID: 21295690
[TBL] [Abstract][Full Text] [Related]
10. IDH1 mutations in gliomas: when an enzyme loses its grip.
Frezza C; Tennant DA; Gottlieb E
Cancer Cell; 2010 Jan; 17(1):7-9. PubMed ID: 20129244
[TBL] [Abstract][Full Text] [Related]
11. Genetic modeling of gliomas in mice: new tools to tackle old problems.
Hambardzumyan D; Parada LF; Holland EC; Charest A
Glia; 2011 Aug; 59(8):1155-68. PubMed ID: 21305617
[TBL] [Abstract][Full Text] [Related]
12. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.
Connolly NP; Stokum JA; Schneider CS; Ozawa T; Xu S; Galisteo R; Castellani RJ; Kim AJ; Simard JM; Winkles JA; Holland EC; Woodworth GF
PLoS One; 2017; 12(3):e0174557. PubMed ID: 28358926
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel genomic markers related to progression to glioblastoma through genomic profiling of 25 primary glioma cell lines.
Roversi G; Pfundt R; Moroni RF; Magnani I; van Reijmersdal S; Pollo B; Straatman H; Larizza L; Schoenmakers EF
Oncogene; 2006 Mar; 25(10):1571-83. PubMed ID: 16247447
[TBL] [Abstract][Full Text] [Related]
14. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
[TBL] [Abstract][Full Text] [Related]
16. Molecular subclassification of diffuse gliomas: seeing order in the chaos.
Huse JT; Phillips HS; Brennan CW
Glia; 2011 Aug; 59(8):1190-9. PubMed ID: 21446051
[TBL] [Abstract][Full Text] [Related]
17. Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma.
Llaguno SA; Chen J; Kwon CH; Parada LF
Cold Spring Harb Symp Quant Biol; 2008; 73():421-6. PubMed ID: 19022744
[TBL] [Abstract][Full Text] [Related]
18. The ecology of brain tumors: lessons learned from neurofibromatosis-1.
Pong WW; Gutmann DH
Oncogene; 2011 Mar; 30(10):1135-46. PubMed ID: 21076468
[TBL] [Abstract][Full Text] [Related]
19. KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.
Brockschmidt A; Trost D; Peterziel H; Zimmermann K; Ehrler M; Grassmann H; Pfenning PN; Waha A; Wohlleber D; Brockschmidt FF; Jugold M; Hoischen A; Kalla C; Waha A; Seifert G; Knolle PA; Latz E; Hans VH; Wick W; Pfeifer A; Angel P; Weber RG
Brain; 2012 Apr; 135(Pt 4):1027-41. PubMed ID: 22427331
[TBL] [Abstract][Full Text] [Related]
20. Mouse models of human cancer as tools in drug development.
Holland EC
Cancer Cell; 2004 Sep; 6(3):197-8. PubMed ID: 15380508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]